Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Timothy S. Regan"'
Publikováno v:
Medical Care. 44:300-303
The objective of this study was to differentiate between 3 measures of antidepressant adherence with regard to the number of patients deemed adherent to therapy and the association between adherence and resource utilization.The authors conducted a re
Publikováno v:
American healthdrug benefits. 2(4)
Publikováno v:
The American journal of managed care. 14(5 Suppl 2)
This article presents background information and highlights key findings from a managed care perspective related to enlarged prostate (EP) in Medicare-eligible patients. This article does not provide a comprehensive review of EP but instead attempts
Publikováno v:
Current medical research and opinion. 23(10)
To review the evidence evaluating the efficacy of vardenafil in subgroups of hypertensive patients with erectile dysfunction (ED).Meta-analysis of randomized, double-blinded, placebo-controlled, flexible-dose vardenafil clinical trials that wereor=12
Autor:
Muta M, Issa, Timothy S, Regan
Publikováno v:
The American journal of managed care. 13
The purpose of this manuscript is to provide clinicians, health plan decision makers, and policy makers with highlights of key findings pertaining to our current understanding of the condition of enlarged prostate (EP) from a managed care perspective
Publikováno v:
Current medical research and opinion. 21(10)
To evaluate differential compliance rates between immediate-release (IR) selective serotonin reuptake inhibitors (SSRI) and a controlled-release (CR) SSRI in patients initiating SSRI therapy.A retrospective analysis of patients initiating treatment w
Publikováno v:
The American journal of managed care. 11
As the antidepressant market continues to expand, it is important for healthcare decision makers to develop clinically and economically sound drug benefit designs. As such, the purpose of this study was to determine the economic implications of a gen
Publikováno v:
Journal of managed care pharmacy : JMCP. 11(2)
OBJECTIVE: Administrative claims data analysis performed in the early 1990s found lower total medical costs for patients with depression who remained on antidepressant therapy with selective serotonin reuptake inhibitors (SSRIs) for at least 90 days
Publikováno v:
Journal of clinical psychopharmacology. 24(5)
Early antidepressant discontinuation has been linked to significant clinical and economic consequences. Clinical practice guidelines suggest that treatment should last for at least 3 to 9 months into the continuation phase; however, 30% of patients d
Autor:
Timothy S. Regan, Lucinda L. Maine
Publikováno v:
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996). 38(2)